Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Press Release on Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2025.".
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has informed the exchanges about a press release dated January 22, 2026, covering its unaudited financial results for the third quarter (October–December 2025) and the nine months ended December 31, 2025. The filing itself does not contain the actual numbers — it only notifies that the press release has been issued. Investors will need to review the detailed results to assess revenue, profit, and margin performance for the quarter and year-to-date period.
This is a routine quarterly results disclosure required by listing rules. The actual stock reaction will depend on the numbers inside the press release — particularly revenue growth, margins, and profit trajectory compared to expectations and the previous quarter.